CVR 45663205Private limited company (ApS)Fremstilling af farmaceutiske præparater (212000)København KFounded 7 Jun 2025
Employees
4
CVR registry, Aug 2026
Result
-8.2M
DKK, annual report 2025
Equity
27.6M
DKK, annual report 2025
1 registered in CVR.
P-number 1031399137Farvergade 10, 1463 København K
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about QuantumCell ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexLUNDBECKFOND INVEST A/SCVR 21855545, 15% to under 20% of capital and votes, since 15 Oct 2025
Novo Holdings A/SCVR 24257630, 15% to under 20% of capital and votes, since 15 Oct 2025
and 5 moreMads Kristian Dalsgaardsince 1 Dec 2025
Saraswati Rudraji Kenkare-Mitrasince 1 Aug 2026
CVR 2185554515% to under 20% of capital and votessince 15 Oct 2025
CVR 2425763015% to under 20% of capital and votessince 15 Oct 2025
CVR 4347820610% to under 15% of capital and votessince 10 Jul 2026
10% to under 15% of capital and votessince 15 Oct 2025
15% to under 20% of capital and votessince 15 Oct 2025
5% to under 10% of capital and votessince 10 Jul 2026
5% to under 10% of capital and votessince 2 Apr 2026
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
33.3% to under 50% of capital and votes7 Jun 2025 to 15 Oct 2025
CVR 4067316433.3% to under 50% of capital and votes7 Jun 2025 to 15 Oct 2025
CVR 438319255% to under 10% of capital and votes7 Jun 2025 to 10 Jul 2026
CVR 459157865% to under 10% of capital and votes15 Oct 2025 to 10 Jul 2026
10% to under 15% of capital and votes15 Oct 2025 to 8 Jun 2026
CVR records founders at incorporation. It does not record whether they are alive or still involved.
7 Jun 2025 to 2 Nov 2026.
7 Jun 2025 to 2 Nov 2026.
| Metric | 2025 |
|---|---|
| Operating profit | -8,781 |
| Result for the year | -8,192 |
| Equity | 27,589 |
| Total assets | 31,425 |
| Employees (average) | 1 |
| Credit metrics (Dandex calculations) | |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -29,244note 1 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. 2025 covers 7 months (7 Jun to 31 Dec 2025).
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. No cash flow statement filed (class A and B are exempt).
Annual report 2025
7 Jun 2025 to 31 Dec 2025, published 9 Jun 2026
QuantumCell ApS has new leadership, a good time to reach out.
Signal, a Dandex estimate. Lapses 9 Nov 2026.
QuantumCell ApS has new leadership, a good time to reach out.
Signal, a Dandex estimate. Lapses 14 Nov 2026.
QuantumCell ApS has changed ownership. A new strategy and new needs can be expected.
Signal, a Dandex estimate. Lapses 14 Nov 2026.
QuantumCell ApS has moved to a new address, with a potential need for new suppliers.
Signal, a Dandex estimate. Lapses 30 Nov 2026.
No other current company drawn.
No other current company drawn.
No other current company drawn.
